Rating History for Blueprint Medicines (BPMC) by Citi

More Stocks Rated by Citi | Latest Ratings for BPMC
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/4/2025 David Lebowitz Upgrade Neutral
(N/A)		 129.00
(83.00)		 127.79
(129.46)		 1.31% Details